Herein, we describe three novel mutations in ATP2B3 found in four unrelated patients presented with clinical features varying widely and ranging from the neurodevelopmental delay with early–onset seizures to acute and severe neurological disease with psychomotor regression in the first years of life. This evidence concerns the gene ATP2B3 and nervous system disorder.